BREAKING: Senate Investigation Finds FDA Officials Covered-Up 25 COVID Shot Safety Signals

The Senate’s recent investigation revealed roughly 25 statistically significant safety signals linked to COVID‑19 vaccinations. Among the adverse events flagged were Bell’s palsy, various forms of cardiac failure, cerebral artery occlusion, basal ganglia stroke, and sudden cardiac death. These findings emerged from a novel analytical method that unmasked patterns previously obscured by the agency’s standard monitoring system, challenging the narrative that vaccine side effects are uniformly minor.

According to the report, senior FDA officials actively suppressed the dissemination of these results. Dr. Sharfman, a researcher at the Center for Education and Drug Abuse Research (CEDAR), faced repeated cease‑and‑desist orders after her analysis highlighted the concerning signals. Internal communications suggest the agency feared the data could fuel anti‑vaccine sentiment, prompting a concerted effort to limit external communication and maintain the status quo.

The episode underscores broader concerns about regulatory transparency and the robustness of vaccine safety surveillance. When critical safety data is concealed, public trust erodes, potentially influencing vaccine uptake and policy decisions. Stakeholders in public health, biotech, and compliance must advocate for clearer reporting mechanisms and independent oversight to ensure that adverse event monitoring remains rigorous, unbiased, and responsive to emerging scientific evidence.